VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO GI 2023 | Clinical requirements for managing immune-related adverse events

Yinghong Wang, MD, PhD, MS, The University of Texas MD Anderson Cancer Center, Houston, TX, provides an overview of factors clinicians should consider when treating immune-related adverse events in patients with gastrointestinal cancers. Familiarity of the specific disease, as well as knowledge of available treatment options and long-term outcomes are necessary to improve the quality of care patients can receive. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter